As of Jun 28
| +0.07 / +6.31%|
The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 1.50, with a high estimate of 12.00 and a low estimate of 0.90. The median estimate represents a +27.12% increase from the last price of 1.18.
The current consensus among 7 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.